BIVI NASDAQ
Credit Risk of going bust: higher than 72% of companies Debt: 2.2% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.01 (down 99.5%), BioVie Inc. would be worth roughly what it owes.
Total debt $275K against a stock market value of $12.5M.
Distance to default 3.25 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $138K (short-term plus half of long-term), stock volatility 120.0%; Altman Z'' -88.78. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Carson City, NV 89703
US
BioVie Inc. is a clinical-stage biotechnology firm primarily dedicated to the discovery, development, and commercialization of innovative drug treatments across the United States. The company's developmental portfolio includes BIV201, a therapeutic agent that has successfully completed its Phase IIa clinical trial for addressing ascites resulting from chronic liver cirrhosis. Additionally, BioVie is advancing NE3107, which is currently undergoing a Phase III clinical trial for the management of mild to moderate Alzheimer's disease, and is also in a Phase I clinical trial for the treatment of Parkinson's disease. Further preclinical investigations are underway for NE3107, exploring its potential applications in treating multiple myeloma and prostate cancer. Established in 2013, the company adopted its current name, BioVie Inc., in July 2016, having previously operated as NanoAntibiotics, Inc. Its corporate headquarters are situated in Carson City, Nevada.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| KIM JOANNE WENDY | P-Purchase | 2,500 | $2.18 | 2026-08-28 |
| Palumbo Joseph M | P-Purchase | 4,843 | $2.16 | 2026-08-28 |
| Chappell Amy Suzon | P-Purchase | 727 | $2.16 | 2026-08-28 |
| DO CUONG V | P-Purchase | 15,210 | $2.08 | 2026-08-27 |
| Palumbo Joseph M | A-Award | 132,000 | $1.31 | 2026-01-05 |